Seaport Therapeutics, Inc. Common Stock (SPTX) vs Savara Inc. (SVRA)
A side-by-side comparison of Seaport Therapeutics, Inc. Common Stock and Savara Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SPTX
Seaport Therapeutics, Inc. Common Stock
$17.37HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SVRA
Savara Inc.
$4.65HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — SPTX vs SVRA
growth of $100 · dividends reinvested · last 1ySPTX -6.8% (-6.8%/yr)SVRA -1.4% (-1.4%/yr)SVRA compounded faster over this window
SPTX SVRA
SPTX vs SVRA: by the numbers
- •SVRA is the larger company ($953M vs $930M market cap).
Metrics side by side
Valuation
| Metric | SPTX | SVRA |
|---|---|---|
| P/B ratio | 2.20 | 6.63 |
Profitability
| Metric | SPTX | SVRA |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | N/A | -96.97% |
| ROIC | -36.95% | -82.30% |
Growth (annualized)
| Metric | SPTX | SVRA |
|---|---|---|
| Total return CAGR (5Y) | N/A | 29.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.